Inovio Pharmaceuticals (INO) 10-Q2004 Q3 Quarterly report

Filed: 15 Nov 04, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Good

New words: academic, ACQUISITION, advance, advanced, advancement, advisory, analyst, APB, area, assessing, assessment, assimilating, attest, breast, broad, broadly, candidate, capability, carefully, Committee, commonly, competing, complement, complementary, complexity, compromise, constitute, content, country, demonstrate, demonstrating, detention, devote, difficulty, discovery, diversion, DIVERT, domestic, education, encouraged, enhancing, enrollment, ethical, exerted, exhaustive, expended, Florida, forecast, frequency, geographic, greatly, half, halt, halted, Health, immaterial, impede, implementation, implemented, imposed, IMPOSING, imposition, inaccurate, incurrence, infrastructure, intangible, integrate, integration, investigate, larger, legislation, level, maintenance, mandatory, monitor, monitoring, national, Navy, NDA, negotiate, negotiation, notice, offset, order, overcoming, overly, oversight, perception, policy, portrayal, preclude, preclusion, priority, profile, prolong, promotion, promotional, pronouncement, prospective, RAC, ratio, reaction, readily, recent, Recombinant, recurrent, referenced, Reform, remediate, remediated, Retroactive, reverse, role, safe, Satisfaction, segregation, Senate, simply, SKILLED, South, split, state, stricter, suggest, summary, surveillance, suspension, timetable, Track, Trademark, Transition, true, typically, uneven, unintentional, University, unqualified, unsafe, withdrawal

Removed: assisted, Avtar, Black, build, caption, cautionary, conform, consist, curtailed, customer, decreased, deny, departing, deployment, Dhillon, Dietmar, disclosed, duly, electrically, employment, ensuring, entirety, expressed, fruitful, industry, intended, inventory, leave, obligation, outlook, penetration, people, pose, positioned, President, processed, projected, qualified, Rabussay, referred, reflect, replace, separately, stay, subsequent, summarized, talent, term, trend, update, Vice

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

INO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Genetronics Biomedical Corporation (the “Company”) on Form 10-Q for the quarter ending September 30, 2004, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Avtar Dhillon

Avtar Dhillon
President and Chief Executive Officer
(Principal Executive Officer)
November 15, 2004


/s/ Peter Kies

Peter Kies
Chief Financial Officer
(Principal Financial and Accounting Officer)
November 15, 2004

A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 HAS BEEN
PROVIDED TO THE COMPANY AND WILL BE RETAINED BY THE COMPANY AND FURNISHED TO THE
SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.